The aim of this study was to determine the effects of platelet-rich plasma (PRP) treatment on pain, functionality, quality of life, and cartilage thickness in patients with knee osteoarthritis (OA).
METHODS:
Sixty patients with chronic knee pain were randomly separated into two groups. The first group was administered 4-ml PRP intra-articularly (IA) in three doses at one-week intervals, and the second group had only one dose of a 4-ml saline solution IA. The patients’ pain was measured using the Visual Analogue Scale (VAS); functionality was measured using the Western Ontario and McMaster University Osteoarthritis Index (WOMAC). The distal femur cartilage thickness was assessed using ultrasonography (USG).
RESULTS:
All baseline parameters were similar ( 0.05). In the first and sixth months after the treatment, the VAS scores of the PRP group were significantly low ( 0.001). In the same group, only the pain sub-score was low in the WOMAC assessment in the first month after treatment. However, in the sixth month, all parameters of the WOMAC score were lower than those of the placebo group ( 0.05). Cartilage thickness measurements were similar in the two groups ( 0.05).
CONCLUSION:
PRP treatment had positive effects on the pain, physical function, and quality of life of patients with knee OA, but it did not increase cartilage thickness.
LiuYZhangHLiangNFanWLiJHuangZ, et al. Prevalence and associated factors of knee osteoarthritis in a rural chinese adult population: An epidemiological survey. BMC Public Health. 2015; 16(1): 94.
2.
SadabadHNBehzadifarMArastehFBehzadifarMDehghanHR. Efficacy of platelet-rich plasma versus hyaluronic acid for treatment of knee osteoarthritis: A systematic review and meta-analysis. Electron Physician. 2016; 8(3): 2115-22.
3.
McAlindonTBannuruRSullivanMArdenNBerenbaumFBierma-ZeinstraS, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014; 22(3): 363-88.
4.
FernandesLHagenKBijlsmaJAndreassenOChristensenPConaghanP, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis. 2013; 72(7): 1125-35.
5.
HochbergMAltmanRAprilKBenkhaliMGuyattGMcGowanJ, et al. American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care & Research. 2012; 64(4): 465-74.
6.
National Clinical Guideline C. National Institute for Health and Clinical Excellence: Guidance. Osteoarthritis: Care and Management in Adults. London: National Institute for Health and Care Excellence (UK). 2014.
7.
GormeliGGormeliCAAtaogluBColakCAslanturkOErtemK. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: A randomized, double-blind, placebo-controlled trial. Knee Surgery, Sports Traumatology, Arthroscopy: Official Journal of the ESSKA. 2015; 25(3): 958-65.
8.
LaudyABBakkerEWRekersMMoenMH. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: A systematic review and meta-analysis. British Journal of Sports Medicine. 2015; 49(10): 657-72.
9.
OrnettiPNourissatGBerenbaumFSellamJRichettePChevalierX. Does platelet-rich plasma have a role in the treatment of osteoarthritis? Joint Bone Spine. 2016; 83(1): 31-6.
10.
SpakováTRosochaJLackoMHarvanováDGharaibehA. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. American Journal of Physical Medicine & Rehabilitation. 2012; 91(5): 411-7.
11.
SanchezMFizNAzofraJUsabiagaJAduriz RecaldeEGarcia GutierrezA, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012; 28(8): 1070-8.
12.
VaquerizoVPlasenciaMArribasISeijasRPadillaSOriveG, et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-endoret) versus durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: A randomized controlled trial. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2013; 29(10): 1635-43.
13.
RaeissadatSRayeganiSHassanabadiHFathiMGhorbaniEBabaeeM, et al. Knee osteoarthritis injection choices: Platelet- rich plasma (PRP) versus hyaluronic acid (A one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskelet Disord. 2015; 8: 1-8.
14.
ColeBKarasVHusseyKPilzKFortierL. Hyaluronic acid versus platelet-rich plasma a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. The American Journal of Sports Medicine. 2016.
15.
CerzaFCarniSCarcangiuADi VavoISchiavillaVPecoraA, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012; 40(12): 2822-7.
16.
FilardoGDi MatteoBDi MartinoAMerliMCenacchiAFornasariP, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation a randomized controlled trial. The American Journal of Sports Medicine. 2015; 43(7): 1575-82.
17.
PatelSDhillonMAggarwalSMarwahaNJainA. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double-blind, randomized trial. Am J Sports Med. 2013; 41(2): 356-64.
18.
SmithP. Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis an fda-sanctioned, randomized, double-blind, placebo-controlled clinical trial. The American Journal of Sports Medicine. 2016; 44(10).
19.
Bar-OrDRaelLBrodyE. Use of saline as a placebo in intra-articular injections in osteoarthritis: Potential contributions to nociceptive pain relief. The Open Rheumatology Journal. 2017; 11: 16-22.
20.
SakataRMcNarySMiyatakeKLeeCVan den BogaerdeJMarderR, et al. Stimulation of the superficial zone protein and lubrication in the articular cartilage by human platelet-rich plasma. The American Journal of Sports Medicine. 2015; 43(6): 1467-73.
21.
BennellKHunterDPatersonK. Platelet-rich plasma for the management of hip and knee osteoarthritis. Current Rheumatology Reports. 2017; 19(5): 24.
22.
ShenLYuanTChenSXieXZhangC. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery and Research. 2017; 12(1): 16.
23.
YinWXuHShengJAnZGuoSXieX, et al. Advantages of pure platelet-rich plasma compared with leukocyte-and platelet-rich plasma in treating rabbit knee osteoarthritis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2016; 22: 1280.
24.
SampsonSReedMSilversHMengMMandelbaumB. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: A pilot study. American Journal of Physical Medicine & Rehabilitation. 2010; 89(12): 961-9.
25.
HalpernBChaudhurySRodeoSAHayterCBognerEPotterH, et al. Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis. Clin J Sport Med. 2013; 23(3): 238-9.
26.
CalisHSutbeyazSGulerEHaliciCSayanHKocA, et al. Efficacy of intra-articular autologous platelet rich plasma application in knee osteoarthritis. Turkish Journal of Rheumatology. 2015; 30(3): 198-206.
27.
ChangKHungCAliwargaFWangTHanDChenW. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: A systematic review and meta-analysis. Arch Phys Med Rehabil. 2014; 95(3): 562-75.
28.
AssirelliEFilardoGMarianiEKonERoffiAVaccaroF, et al. Effect of two different preparations of platelet-rich plasma on synoviocytes. Knee Surgery, Sports Traumatology, Arthroscopy. 2015; 23(9): 2690-703.
29.
FilardoGKonEPereira RuizMVaccaroFGuitaldiRDi MartinoA, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single-versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012; 20(10): 2082-91.
30.
RibohJSaltzmanBYankeAFortierLColeB. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. The American Journal of Sports Medicine. 2016; 44(3): 792-800.
31.
MarianiECanellaVCattiniLKonEMarcacciMDi MatteoB, et al. Leukocyte-rich platelet-rich plasma injections do not up-modulate intra-articular pro-inflammatory cytokines in the osteoarthritic knee. PloS One. 2016; 11(6).
32.
CavalloCRoffiAGrigoloBMarianiEPratelliLMerliG, et al. Platelet-rich plasma: The choice of activation method affects the release of bioactive molecules. BioMed Research International. 2016.
